TI  - Adenosine Pathway-Based Prognostic Signature  for Predicting Clinical Outcomes and Immune Microenvironment Characteristics in Epithelial Ovarian Cancer
AU  - Ibrahimov, A.
AU  - Novruzova, F.
SO  - Journal of Clinical Practice and Research 2026;48:302-313.
DO  - 10.14744/cpr.2026.51733